Trials / Terminated
TerminatedNCT01316133
A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients
A Multicenter, Non-comparative, Open-labeled, Prospective Study to Evaluate the Efficacy and Safety of Tacrolimus (Prograf®) With Steroid in Korean Lupus Nephritis Patients Who Are Non-responders to Steroid Monotherapy
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Astellas Pharma Korea, Inc. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study is to evaluate efficacy and safety of tacrolimus with steroid by observing remission rate at 24 weeks in lupus nephritis patients who are non-responders to steroid monotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tacrolimus | oral |
Timeline
- Start date
- 2011-04-19
- Primary completion
- 2016-04-08
- Completion
- 2016-04-08
- First posted
- 2011-03-16
- Last updated
- 2024-10-31
Locations
7 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01316133. Inclusion in this directory is not an endorsement.